These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36368694)

  • 21. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
    Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
    Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women.
    Liu S; Chen R; Ding N; Wang Q; Huang M; Liu H; Xie Z; Ou Y; Sheng Z
    J Endocrinol Invest; 2021 Feb; 44(2):347-352. PubMed ID: 32495298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Good is Our Best Guess? Clinical Application of the WHO FRAX Tool in Osteoporotic Fracture Risk Determination and Treatment Decisions.
    Hinz L; Freiheit E; Kline G
    Calcif Tissue Int; 2016 Aug; 99(2):114-20. PubMed ID: 27038319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and application of FRAX in the management of osteoporosis in Ireland.
    McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
    Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
    Dimai HP; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; Fahrleitner-Pammer A; Pietschmann P; Muschitz C; McCloskey EV; Kanis JA
    Arch Osteoporos; 2022 Nov; 17(1):141. PubMed ID: 36357621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low bone density, vertebral fracture and FRAX score in kidney transplant recipients: A cross-sectional cohort study.
    Velioglu A; Kaya B; Aykent B; Ozkan B; Karapinar MS; Arikan H; Asicioglu E; Bugdaycı O; Yavuz DG; Tuglular S
    PLoS One; 2021; 16(4):e0251035. PubMed ID: 33930070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone Mineral Density of the 1/3 Radius Refines Osteoporosis Diagnosis, Correlates With Prevalent Fractures, and Enhances Fracture Risk Estimates.
    Tripto-Shkolnik L; Vered I; Peltz-Sinvani N; Kowal D; Goldshtein I
    Endocr Pract; 2021 May; 27(5):408-412. PubMed ID: 33934751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
    Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES;
    Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
    Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
    Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
    Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
    Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of using non-hip bone density inputs with FRAX®.
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Mar; 23(3):853-60. PubMed ID: 22008881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease.
    Whitlock RH; Leslie WD; Shaw J; Rigatto C; Thorlacius L; Komenda P; Collister D; Kanis JA; Tangri N
    Kidney Int; 2019 Feb; 95(2):447-454. PubMed ID: 30579724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
    Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
    BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS).
    Chen JF; Yu SF; Hsu CY; Chiu WC; Wu CH; Lai HM; Chen YC; Su YJ; Chen JF; Cheng TT
    Arch Osteoporos; 2019 Oct; 14(1):101. PubMed ID: 31650396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.